North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

The stock's fall snapped a three-day winning streak.

We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...

Shares of Abbott Laboratories ABT rose 2.29% to $132.06 Wednesday, on what proved to be an all-around positive trading ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

Elon Musk's X is suing more companies, alleging they joined a group of advertisers illegally conspiring to boycott the social ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

Over the past year, many Abbott Laboratories (NYSE:ABT) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that the stock is may be overbought. Next earnings report is scheduled for 82 days ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Abbott Laboratories (ABT – Research Report), ...